The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Killing cancer cells
- Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance | npj Precision Oncologyon March 2, 2021 at 8:35 am
Resistance to therapy remains an obstacle to successful treatment of most cancer. For instance, in pancreatic cancer particularly, a challenging tumor microenvironment and unknown factors contribute ...
- Missing even ONE mammogram screening before a breast cancer diagnosis can increase your risk of death by 41 per cent, study warnson March 2, 2021 at 7:00 am
Researchers analysed health data on nearly 550,000 women from nine Swedish counties who were eligible for breast cancer screening between 1992 and 2016.
- Antibodies deplete cancer cells in mice and human cell lines; reach previously inaccessible targetson March 2, 2021 at 6:12 am
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power ...
- Scientists test the effect of natural product isolated from sea sponge on cancer cellson March 1, 2021 at 5:55 pm
Scientists from Far Eastern Federal University together with Russian and German colleagues, continue studying antitumor compounds synthesized based on bioactive molecules isolated from a sea sponge.
- Natural product isolated from sea sponge tested against cancer cellson March 1, 2021 at 10:41 am
Scientists from Far Eastern Federal University (FEFU) together with Russian and German colleagues, continue studying antitumor compounds synthesized based on bioactive molecules isolated from a sea ...
Go deeper with Google Headlines on:
Killing cancer cells
Go deeper with Bing News on:
Anti-cancer activity
- Sequential treatment with immunotherapy and checkpoint inhibitors prolongs anti-tumor activityon March 2, 2021 at 9:00 am
Advanced melanoma is one of the deadliest types of cancer, with a 5-year survival rate of only 27% for patients with distant metastases. Recent advances in targeted therapies and immunotherapies have ...
- Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drugon March 2, 2021 at 8:59 am
Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that it has entered into an agreement with ...
- Computational modelling of nanotube delivery of anti-cancer drug into glutathione reductase enzymeon March 2, 2021 at 8:48 am
Density functional theory method combined with docking and molecular dynamics simulations are used to understand the interaction of carmustine with human glutathione reductase enzyme. The active site ...
- CytomX Therapeutics, Inc. (CTMX) Q4 2020 Earnings Call Transcripton February 25, 2021 at 6:01 am
Q4 2020 Earnings CallFeb 24, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, ladies and gentlemen, thank you for ...
- Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Conferenceon February 24, 2021 at 11:56 pm
inhibitor that increases the anti-tumor activity of standard chemotherapy, radiotherapy, and immunotherapy without increasing toxicity. LB-100 is initially being evaluated in three clinical ...